Postpartum Care Support for Gestational Diabetes and Hypertension
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to assist new mothers who experienced gestational diabetes or high blood pressure during pregnancy. It seeks to connect these women to primary care for ongoing health checks after childbirth. Participants will receive education, support, and regular check-ins to ensure optimal care. Women who have recently given birth, had gestational diabetes or pregnancy-related high blood pressure, and attended prenatal care in the last six months may be suitable candidates. The trial compares usual care with a new support program, which includes OB Provider Clinical Decision Support (CDS) and other interventions, to determine which is more effective. As a Phase 3 trial, this study represents the final step before FDA approval, offering participants a chance to contribute to potentially groundbreaking healthcare advancements.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that Clinical Decision Support Systems (CDSS) in maternity care are increasingly common and can enhance safety and outcomes. These systems assist healthcare providers in making better decisions. Although specific safety data for postpartum care support treatments like OB Provider Clinical Decision Support and Primary Care Provider Clinical Decision Support are not detailed, the widespread use of CDSS indicates its acceptance in healthcare settings.
Text messaging interventions have demonstrated positive results in managing conditions like gestational diabetes. Studies suggest that these mobile health tools can improve pregnancy outcomes and aid in lifestyle changes.
Patient education, whether in an OB or primary care setting, is generally considered safe and aims to inform and support patients in managing their health.
Patient outreach, which involves contacting patients to keep them engaged in their care, is also a well-regarded approach for improving health outcomes.
Overall, these components of the STEP-UP trial rely on methods commonly used and well-tolerated in healthcare.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores a comprehensive approach to postpartum care, addressing both gestational diabetes and hypertension with a combination of clinical decision support, patient education, and digital outreach. Unlike standard care, which typically involves routine check-ups and medication management, this new approach integrates seamless communication through text messaging and proactive outreach to ensure continuous care and monitoring. By promoting linkage to primary care and ongoing evaluation, this method aims to improve long-term health outcomes for postpartum women, potentially offering a more personalized and efficient care experience.
What evidence suggests that this trial's treatments could be effective for postpartum care support?
Research has shown that many women who experienced gestational diabetes (GDM) or high blood pressure during pregnancy (HDP) often do not continue with specialized care after giving birth. For instance, only about one in three women with GDM and half of those with HDP see a primary care doctor within six months postpartum. The STEP-UP program in this trial aims to change this by helping these women connect with primary care and supporting regular health check-ups. Studies suggest that programs like STEP-UP can improve follow-up care and may lower long-term health risks. Although more research is needed for firm conclusions, early results are promising in closing the gaps in postpartum care.16789
Who Is on the Research Team?
Stacy Bailey, PhD MPH
Principal Investigator
Northwestern University
Are You a Good Fit for This Trial?
The STEP-UP trial is for postpartum women over 18 who had gestational diabetes or hypertension during pregnancy. Participants must have attended a prenatal care visit at a study site within the last 6 months and speak English or Spanish.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
STEP-UP intervention promoting linkage to primary care and ongoing chronic disease evaluation for postpartum women with prior GDM and/or HDP
Follow-up
Participants are monitored for completion of primary care visits and dysglycemia testing
What Are the Treatments Tested in This Trial?
Interventions
- OB Provider Clinical Decision Support (CDS)
- Patient Education (OB Visit)
- Patient Education (Primary Care Visit)
- Patient Outreach
- Primary Care Provider Clinical Decision Support (CDS)
- Text messaging
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwestern University
Lead Sponsor
AllianceChicago
Collaborator
Cook County Health
Collaborator